Company intelligence / Profile preview

PDFE Pharma Innovations

Dubayy, United Arab Emiratespdfepharma.com ↗
Ownership
Private
Development stage
Other
01

Overview

PDFE Pharma Innovations focuses on pharmaceutical innovations, primarily small molecule drugs, with its lead program in Phase 2 for androgenetic alopecia and other preclinical assets focused on immune and digestive system disorders.

Therapeutic areas
DermatologyGastroenterology
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

PDFE-2304

2
03

Partnerships

Sterin Labs Private Ltd

Beyond the preview

Go deeper on PDFE Pharma Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDFE Pharma Innovations.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call